Butacompren
Brand names,
Butacompren
Analogs
Butacompren
Brand Names Mixture
- Alka Phenyl Tab (Aluminum Hydroxide + Magnesium Trisilicate + Phenylbutazone)
- Alka Phenylbutazone Tab (Aluminum Hydroxide + Magnesium Trisilicate + Phenylbutazone)
- Phenylone Plus Tab (Aluminum Hydroxide + Magnesium Trisilicate + Phenylbutazone)
Butacompren
Chemical_Formula
C19H20N2O2
Butacompren
RX_link
No information avaliable
Butacompren
fda sheet
Butacompren
msds (material safety sheet)
Butacompren
Synthesis Reference
Ullmann's Encyklopaedie der Technischen Chemie 13, 298 (1962)
Butacompren
Molecular Weight
308.374 g/mol
Butacompren
Melting Point
105 oC
Butacompren
H2O Solubility
47.5 mg/L
Butacompren
State
Solid
Butacompren
LogP
4.214
Butacompren
Dosage Forms
Bolus; Liquid; Paste; Powder; Solution; Tablet
Butacompren
Indication
For the treatment of backache and ankylosing spondylitis
Butacompren
Pharmacology
Phenylbutazone is a synthetic, pyrazolone derivative. It is a nonhormonal anti-inflammatory, antipyretic compound useful in the management of inflammatory conditions. The apparent analgesic effect is probably related mainly to the compound's anti-inflammatory properties and arise from its ability to reduce production of prostaglandin H and prostacyclin. Prostaglandins act on a variety of cells such as vascular smooth muscle cells causing constriction or dilation, on platelets causing aggregation or disaggregation and on spinal neurons causing pain. Prostacylcin causes vascular constriction platelet disaggregation
Butacompren
Absorption
No information avaliable
Butacompren
side effects and Toxicity
Oral, LD50 = 238 mg/kg (mouse); Oral, LD50 = 781 mg/kg (rabbit); Oral, LD50 = 245 mg/kg (rat); Oral, LD50 = 375 mg/kg (rat)
Butacompren
Patient Information
No information avaliable
Butacompren
Organisms Affected
Humans and other mammals